Markets.com Logo
markets.com

CNTRF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

CNTRF.US represents shares of Centrus Energy Corp, a company based in the United States that supplies nuclear fuel and services for the nuclear power industry. Specifically, Centrus focuses on uranium enrichment, a critical step in the nuclear fuel cycle, and also works on advanced reactor technologies. The company aims to provide reliable and cost-effective fuel solutions to its customers while playing a role in the development of next-generation nuclear energy technologies.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Company Performance: Century Therapeutics' financial health, clinical trial results, and progress in developing cell therapies significantly influence its stock price. Positive data boosts investor confidence, while setbacks can trigger declines.

Broader Market Trends: General market conditions, including economic growth, interest rates, and investor sentiment, affect most stocks. A bullish market often lifts CNTRF.US, while a bearish one can depress it.

Industry Dynamics: Developments in the cell therapy and biotechnology industries, such as regulatory changes, competitor advancements, and technological breakthroughs, impact investor perceptions of Century Therapeutics' potential.

Regulatory Approvals: Approval of Century Therapeutics' therapies by regulatory bodies like the FDA is a major catalyst for stock price increases. Conversely, rejection or delays negatively affect the price.

Partnerships & Collaborations: Strategic alliances, licensing agreements, and collaborations with other pharmaceutical or biotech companies can positively influence CNTRF.US by validating Century's technology and expanding its market reach.

News & Announcements: Significant news releases about Century Therapeutics, including earnings reports, research publications, and management changes, can create volatility and impact the stock price.

Investor Sentiment: Overall investor attitudes and expectations regarding the company and its future prospects play a crucial role. Positive sentiment drives demand, while negative sentiment can lead to selling pressure.

Competition: The competitive landscape within the cell therapy sector affects CNTRF.US. The emergence of competing therapies or companies with superior technology can negatively impact Century Therapeutics' valuation.

Funding & Capital: Century Therapeutics' ability to secure funding through public offerings, private placements, or debt financing influences its financial stability and future growth prospects, which in turn affects the stock price.

Technological Advancements: Breakthroughs in cell therapy technology and Century Therapeutics' ability to adopt and implement these advancements can significantly impact its competitive advantage and market value.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com